See analyst estimates and all valuation multiples for Chemicals
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $236B | 7.1x | 18.0x | |
| $97.8B | 4.2x | 21.3x | |
| $83.5B | 5.2x | 22.4x | |
| $80.2B | 6.7x | 15.9x | |
| $69.6B | 0.9x | 7.7x | |
| $52.1B | 25.0x | 1391.6x | |
| $48.0B | 2.7x | 7.0x | |
| $47.4B | 3.2x | 16.5x | |
| $44.4B | 1.2x | 8.5x | |
| $42.7B | 1.6x | 7.5x | |
| $37.7B | 1.4x | 8.3x | |
| $36.6B | 0.9x | 8.1x | |
| $36.6B | 2.9x | 11.3x | |
| $34.8B | 7.3x | 19.7x | |
| $32.3B | 2.0x | 11.3x | |
| $32.1B | 1.0x | 8.7x | |
| $31.1B | 0.9x | 8.5x | |
| $31.0B | 0.9x | 6.6x | |
| $30.3B | 2.0x | 11.5x | |
| $28.5B | 2.6x | 13.3x | |
| $26.6B | 6.6x | 36.8x | |
| $26.5B | 2.2x | 13.2x | |
| $23.7B | 4.1x | 10.2x | |
| $21.0B | 2.3x | 10.2x | |
| $20.3B | 3.4x | 10.1x | |
| $19.4B | 4.4x | 16.2x | |
| $18.6B | 0.5x | 2.3x | |
| $18.6B | 1.9x | 8.6x | |
| $18.1B | 7.1x | 24.1x | |
| $17.4B | 3.3x | 12.1x | |
| $16.9B | 2.8x | 13.6x | |
| $16.8B | 1.3x | 9.6x | |
| $16.8B | 2.7x | 6.9x | |
| $16.5B | 2.2x | 14.3x | |
| $16.5B | 1.0x | 13.8x | |
| $14.0B | 3.1x | 9.3x | |
| $13.8B | 1.2x | 7.4x | |
| $13.6B | 1.5x | 7.8x | |
| $13.6B | 0.9x | 5.6x | |
| $13.4B | 0.8x | 5.6x | |
| $13.3B | 2.6x | 13.1x | |
| $11.8B | 3.8x | 10.4x | |
| $11.0B | 4.9x | 11.8x | |
| $10.8B | 1.6x | 6.3x | |
| $9.9B | 1.3x | 6.2x | |
| $9.4B | 0.5x | 5.6x | |
| $9.2B | 1.6x | 13.4x | |
| $9.0B | 2.1x | 10.0x | |
| $8.8B | 0.8x | 5.1x | |
| $8.2B | 0.6x | 3.1x | |
| $6.9B | 7.2x | 26.9x | |
| $6.6B | 3.0x | 8.9x | |
| $6.6B | 2.4x | 272.0x | |
| $6.3B | 1.5x | 10.1x | |
| $5.9B | 1.2x | 9.8x | |
| $5.6B | 1.0x | 4.7x | |
| $5.5B | 2.8x | 11.0x | |
| $5.5B | n/a | n/a | |
| $5.4B | 0.7x | 7.8x | |
| $5.4B | 1.0x | 6.3x | |
| $5.4B | 0.6x | 6.8x | |
| $5.4B | 6.6x | 23.0x | |
| $4.8B | 0.7x | 5.7x | |
| $4.8B | 1.9x | 14.0x | |
| $4.5B | 0.4x | 12.7x | |
| $4.3B | n/a | n/a | |
| $3.7B | 1.7x | 8.4x | |
| $3.6B | 1.1x | 5.5x | |
| $3.6B | 0.9x | 15.5x | |
| $3.5B | n/a | n/a | |
| $3.4B | 12.3x | 53.4x | |
| $3.0B | 5.0x | 27.3x | |
| $2.8B | 0.9x | -157.6x | |
| $2.5B | 0.8x | 7.0x | |
| $2.4B | 0.6x | 3.4x | |
| $2.4B | n/a | n/a | |
| $2.2B | 2.8x | 11.1x | |
| $2.1B | 0.7x | 6.3x | |
| $2.0B | 2.1x | 10.9x | |
| $1.9B | 7.4x | 22.7x | |
| $1.8B | 2.7x | 14.2x | |
| $1.8B | 0.2x | 5.1x | |
| $1.8B | 1.5x | 11.4x | |
| $1.6B | 1.5x | 8.7x | |
| $1.5B | 2.2x | 9.3x | |
| $1.4B | n/a | n/a | |
| $1.4B | 2.6x | n/a | |
| $1.2B | 1.2x | 11.8x | |
| $1.1B | 0.6x | 21.1x | |
| $947M | 0.6x | 6.7x | |
| $939M | 2.2x | 32.3x | |
| $805M | n/a | n/a | |
| $716M | n/a | n/a | |
| $638M | 0.5x | 3.9x | |
| $632M | 1.1x | 7.5x | |
| $592M | n/a | n/a | |
| $586M | 1.2x | 6.0x | |
| $558M | 0.2x | 28.3x | |
| $558M | 0.4x | 6.0x | |
| $498M | 0.9x | 5.6x | |
| $468M | 4.3x | -20.5x | |
| $462M | 8.8x | 28.8x | |
| $460M | 1.2x | 8.8x | |
| $428M | 0.6x | 5.6x | |
| $416M | 0.8x | 2.7x | |
| $406M | 0.7x | 5.4x | |
| $401M | 1.7x | 10.1x | |
| $359M | n/a | n/a | |
| $350M | 0.2x | 3.2x | |
| $348M | 1.5x | 8.3x | |
| $297M | 7.1x | -7.4x | |
| $280M | n/a | n/a | |
| $275M | 0.5x | 6.9x | |
| $263M | n/a | n/a | |
| $251M | n/a | n/a | |
| $222M | n/a | n/a | |
| $200M | n/a | n/a | |
| $198M | 9.0x | -7.5x | |
| $175M | 7689.4x | -555.3x | |
| $171M | 0.4x | 4.3x | |
| $150M | 0.6x | 3.8x | |
| $149M | n/a | n/a | |
| $140M | 1.2x | 6.4x | |
| $129M | 6.1x | 18.5x | |
| $119M | 5.9x | -5.8x | |
| $106M | n/a | n/a | |
| $99.1M | n/a | n/a | |
| $80.0M | 0.8x | 4.3x | |
| $79.1M | n/a | n/a | |
| $75.9M | 0.6x | 8.6x | |
| $75.9M | 23.4x | -2.2x | |
| $75.4M | 335.6x | -12.1x | |
| $70.2M | n/a | n/a | |
| $64.4M | n/a | n/a | |
| $47.5M | 0.5x | 4.5x | |
| $46.2M | 0.8x | 18.3x | |
| $44.2M | 0.5x | 12.5x | |
| $43.8M | n/a | n/a | |
| $41.2M | 2.3x | 14.4x | |
| $36.9M | 0.6x | 14.9x | |
| $34.8M | n/a | n/a | |
| $34.6M | 1.6x | 31.3x | |
| $33.8M | 9.3x | -5.1x | |
| $26.9M | 2.0x | 39.2x | |
| $26.8M | n/a | n/a | |
| $24.2M | n/a | n/a | |
| $21.5M | 2.0x | -10.0x | |
| $21.0M | n/a | n/a | |
| $20.7M | n/a | n/a | |
| $17.9M | n/a | n/a | |
| $16.5M | n/a | n/a | |
| $16.3M | n/a | n/a | |
| $16.3M | n/a | n/a | |
| $15.8M | n/a | n/a | |
| $15.0M | 1.5x | -5.0x | |
| $12.9M | n/a | n/a | |
| $12.4M | n/a | n/a | |
| $10.2M | 2.1x | -7.6x | |
| $8.9M | n/a | n/a | |
| $6.4M | 39.5x | -1.9x | |
| $6.1M | n/a | n/a | |
| $6.0M | 116.0x | -7.8x | |
| $5.5M | n/a | n/a | |
| $5.4M | n/a | n/a | |
| $5.3M | n/a | n/a | |
| $4.1M | n/a | n/a | |
| $3.7M | n/a | n/a | |
| $3.6M | n/a | n/a | |
| $3.3M | n/a | n/a | |
| $2.6M | n/a | n/a | |
| $2.4M | n/a | n/a | |
| $1.9M | n/a | n/a | |
| $1.9M | n/a | n/a | |
| $1.7M | 4.9x | -0.1x | |
| $1.6M | n/a | n/a | |
| $1.1M | n/a | n/a | |
| $1.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Chemicals